Study of SG301 for Renal AMR After Transplantation

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
To evaluate the safety and tolerability of SG301 injection in patients with antibody-mediated rejection (AMR) after renal transplantation.
Epistemonikos ID: f7104abb558ef8765073019f53a8959851a33935
First added on: Aug 14, 2026